Ryan Dunlap - 06 Sep 2022 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Role
Director
Signature
/s/ Antonio Migliarese, Attorney-In-Fact
Issuer symbol
CYDY
Transactions as of
06 Sep 2022
Net transactions value
$0
Form type
4
Filing time
08 Sep 2022, 21:49:01 UTC
Previous filing
06 Sep 2022
Next filing
05 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYDY Non-qualified stock option (right to buy) Award $0 +185,333 $0.000000 185,333 06 Sep 2022 Common Stock 185,333 $0.5000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest in nine equal monthly installments beginning on September 1, 2022, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.